Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-16-004591
Filing Date
2016-02-02
Accepted
2016-02-02 18:09:49
Documents
1
Period of Report
2016-01-29

Document Format Files

Seq Description Document Type Size
1 form4-02022016_030241.html 4  
1 form4-02022016_030241.xml 4 4234
  Complete submission text file 0001415889-16-004591.txt   5659
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 WEST SIERRA MADRE BLVD #392 SIERRA MADRE CA 91024
Business Address
MIRZA ZIAD (Reporting) CIK: 0001538740 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 161382351